Related Experiment Video
Updated: Aug 12, 2026

12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Open vs. robotic prostatectomy using Versius®: perioperative, oncologic & learning curve outcomes
Bara M Hammadeh1, Mohannad Abuhamad2,3, Rami Ghanem4,5
1Al-Balqa' Applied University, Salt, Jordan.
Journal of Robotic Surgery
|August 11, 2026
Summary
Open radical prostatectomy (ORP) and Versius®-assisted robot-assisted radical prostatectomy (RARP) show similar oncologic outcomes. RARP offers reduced blood loss, but requires monitoring for lymph node yield during early adoption.
Area of Science:
- Urology
- Surgical Oncology
- Robotic Surgery
Background:
- Radical prostatectomy is a standard treatment for prostate cancer.
- Evaluating new robotic platforms like Versius® is crucial for surgical advancement.
- Comparing robotic-assisted radical prostatectomy (RARP) with open radical prostatectomy (ORP) provides insights into surgical outcomes and learning curves.
Purpose of the Study:
- To compare perioperative, oncologic, and learning curve outcomes between ORP and Versius®-assisted RARP in Jordan.
- To assess the efficiency and safety of adopting a new robotic surgical system.
- To provide an evidence-based framework for centers implementing Versius®.
Main Methods:
- Prospective observational case series of 133 patients (58 ORP, 75 RARP).
- Comparison of perioperative parameters, pathologic outcomes, and complications using statistical tests.
- Learning curve analysis using operative time, console time, and CUSUM analysis.
Main Results:
- RARP had longer operative time (360 vs. 255 min) but lower blood loss (200 vs. 700 mL) compared to ORP.
- Hospital stay was similar, but ORP patients were more likely to stay ≥4 days.
- Positive surgical margin rates were comparable; lymph node yield was lower in RARP (9 vs. 19).
- Operative efficiency improved beyond case 30 for RARP; blood-loss advantage was immediate, but lymph node deficit persisted.
Conclusions:
- Versius®-assisted RARP demonstrates reduced blood loss and comparable short-term oncologic outcomes to ORP.
- Operative efficiency with Versius® improves significantly after approximately 30 cases.
- Prospective monitoring of lymph node yield is recommended during the early adoption phase of this robotic platform.